Antifungals in the treatment of allergic bronchopulmonary aspergillosis (Q33684335)

28 July 2017

1 reference

title

Antifungals in the treatment of allergic bronchopulmonary aspergillosis (English)

1 reference

allergic bronchopulmonary aspergillosis

28 July 2017

0 references

0 references

author name string

Leon EE

series ordinal

1

1 reference

PubMed ID

10400477

28 July 2017

Craig TJ

series ordinal

2

1 reference

28 July 2017

1 June 1999

1 reference

Annals of Allergy, Asthma & Immunology

28 July 2017

1 reference

28 July 2017

82

1 reference

28 July 2017

6

1 reference

28 July 2017

511-6; quiz 516-9

1 reference

Allergic bronchopulmonary aspergillosis

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Purification of a major allergen, Asp f 2 binding to IgE in allergic bronchopulmonary aspergillosis, from culture filtrate of Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Improved diagnosis of allergic bronchopulmonary aspergillosis with gp66 (formerly antigen 7) of Aspergillus fumigatus for specific IgE detection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

The assessment of immunologic and clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis in corticosteroid-dependent asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Broncho-pulmonary aspergillosis; a review and a report of eight new cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic pulmonary aspergillosis successfully treated with inhalations of nystatin. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Treatment of bronchopulmonary aspergillosis with observations on the use of natamycin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Controlled trial of natamycin in the treatment of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis--a North American Rarity. Clinical and immunologic characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis in a child

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Trial of ketoconazole in non-invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Trial of ketoconazole in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Mucoid Impaction of the Bronchi Apparently Responding to Antifungal Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Treatment of bronchopulmonary aspergillosis with clotrimazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Allergic bronchopulmonary aspergillosis treated with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Itraconazole and allergic bronchopulmonary aspergillosis in twin brothers with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Serologic response to itraconazole in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Itraconazole in the treatment of aspergillosis: a study of 16 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

A case of allergic bronchopulmonary aspergillosis successfully treated with itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Adverse events associated with itraconazole in 189 patients on chronic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Itraconazole concentrations in airway fluid and tissue [letter]

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

Itraconazole resistance in Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963157-2

7 January 2021

10.1016/S1081-1206(10)63157-2

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10400477